Novel therapeutic targets for ARID1A mutant ovarian clear cell carcinoma (OCCC)

被引：0
|
作者：
Miller, R. E. [1 ]
Bajrami, I. [1 ]
Brough, R. [1 ]
Konde, A. [1 ]
Campbell, J. [1 ]
Rafiq, R. [1 ]
Ashworth, A. [1 ]
Lord, C. J. [1 ]
机构：
[1] Inst Canc Res, London SW3 6JB, England
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70444-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
318
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [41] Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
    Stany, Michael P.
    Vathipadiekal, Vinod
    Ozbun, Laurent
    Stone, Rebecca L.
    Mok, Samuel C.
    Xue, Hui
    Kagami, Takashi
    Wang, Yuwei
    McAlpine, Jessica N.
    Bowtell, David
    Gout, Peter W.
    Miller, Dianne M.
    Gilks, C. Blake
    Huntsman, David G.
    Ellard, Susan L.
    Wang, Yu-Zhuo
    Vivas-Mejia, Pablo
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    Birrer, Michael J.
    PLOS ONE, 2011, 6 (07):
  • [42] Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma
    Park, Jeong Hwan
    Lee, Cheot
    Suh, Ja Hee
    Chae, Ji Yoen
    Kim, Hwal Woong
    Moon, Kyung Chul
    HUMAN PATHOLOGY, 2015, 46 (03) : 454 - 460
  • [43] Biomolecular features of ARID1A, HNF1β and ERα in clear cell carcinoma of the ovary
    Abou-Taleb, H.
    Yamaguchi, K.
    Mandai, M.
    Amano, Y.
    Kosaka, K.
    Matsumura, N.
    Baba, T.
    Yoshioka, Y.
    Hamanishi, J.
    Konishi, I
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 : 159 - 160
  • [44] CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
    Kawahara, Naoki
    Yamada, Yuki
    Kobayashi, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [45] Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma
    Jung, Un Suk
    Min, Kyueng-Whan
    Kim, Dong-Hoon
    Kwon, Mi Jung
    Park, HoHyun
    Jang, Hyung Seok
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (01) : 1 - 13
  • [46] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    MODERN PATHOLOGY, 2013, 26 : 289A - 290A
  • [47] Impact of ARID1A mutation on the tumor microenvironment of advanced clear cell ovarian cancer.
    Devlin, Michael-John
    Kristeleit, Rebecca S.
    McDermott, Jacqueline
    Maniati, Eleni
    Laforets, Florian
    Kotantaki, Panoraia
    Miller, Rowan
    Balkwill, Frances
    CANCER RESEARCH, 2021, 81 (13)
  • [48] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    LABORATORY INVESTIGATION, 2013, 93 : 289A - 290A
  • [49] Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
    Ge, Huijuan
    Xiao, Yaoxin
    Qin, Guangqi
    Gu, Yanzi
    Cai, Xu
    Jiang, Wenhua
    Tu, Xiaoyu
    Yang, Wentao
    Bi, Rui
    DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [50] Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
    Huijuan Ge
    Yaoxin Xiao
    Guangqi Qin
    Yanzi Gu
    Xu Cai
    Wenhua Jiang
    Xiaoyu Tu
    Wentao Yang
    Rui Bi
    Diagnostic Pathology, 16
12345